Air Industries Group (AIRI) Analysts See $-0.03 EPS; Lombard Odier Asset Management Switzerland Sa Cut Its Coherus Biosciences (CHRS) Holding

August 10, 2017 - By Marguerite Chambers

Lombard Odier Asset Management Switzerland Sa decreased Coherus Biosciences Inc (CHRS) stake by 25% reported in 2016Q4 SEC filing. Lombard Odier Asset Management Switzerland Sa sold 25,000 shares as Coherus Biosciences Inc (CHRS)’s stock declined 0.89%. The Lombard Odier Asset Management Switzerland Sa holds 75,000 shares with $2.11M value, down from 100,000 last quarter. Coherus Biosciences Inc now has $646.97M valuation. The stock decreased 6.67% or $0.9 during the last trading session, reaching $12.6. About shares traded. Coherus Biosciences Inc (NASDAQ:CHRS) has risen 17.62% since August 10, 2016 and is uptrending. It has outperformed by 0.92% the S&P500.

Analysts expect Air Industries Group Inc (NYSEMKT:AIRI) to report $-0.03 EPS on August, 17.They anticipate $0.01 EPS change or 25.00% from last quarter’s $-0.04 EPS. After having $-0.15 EPS previously, Air Industries Group Inc’s analysts see -80.00% EPS growth. The stock decreased 1.43% or $0.02 on August 9, reaching $1.38. About shares traded. Air Industries Group Inc (NYSEMKT:AIRI) has declined 52.00% since August 10, 2016 and is downtrending. It has underperformed by 68.70% the S&P500.

Air Industries Group is an aerospace and defense company. The company has market cap of $10.56 million. The Firm makes and creates structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines and other components. It currently has negative earnings. The Firm operates in three divisions: Complex Machining, Aerostructures and Electronics and Turbine Engine Components.

Lombard Odier Asset Management Switzerland Sa increased Brunswick Corp (NYSE:BC) stake by 150,000 shares to 350,000 valued at $19.09 million in 2016Q4. It also upped Liberty Interactive Llc (Prn) stake by 330,000 shares and now owns 420,000 shares. Vanguard Intl Equity Index F (VWO) was raised too.

Among 10 analysts covering Coherus Biosciences (NASDAQ:CHRS), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Coherus Biosciences had 15 analyst reports since September 3, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Monday, November 23 by Barclays Capital. Maxim Group initiated Coherus Biosciences Inc (NASDAQ:CHRS) on Wednesday, September 7 with “Buy” rating. The firm has “Buy” rating by Cowen & Co given on Monday, June 12. The stock of Coherus Biosciences Inc (NASDAQ:CHRS) earned “Buy” rating by Maxim Group on Monday, June 12. The rating was initiated by Citigroup with “Buy” on Wednesday, July 27. The stock of Coherus Biosciences Inc (NASDAQ:CHRS) has “Hold” rating given on Thursday, September 3 by Zacks. The company was initiated on Wednesday, January 20 by Credit Suisse. The company was initiated on Wednesday, October 19 by Robert W. Baird.